Literature DB >> 23857816

Adjunctive antidepressant prescriptions for hospitalized patients with schizophrenia in Asia (2001-2009).

Yu-Tao Xiang1, Gabor S Ungvari, Chuan-Yue Wang, Tian-Mei Si, Edwin H M Lee, Helen F K Chiu, Kelly Y C Lai, Yan-Ling He, Shu-Yu Yang, Mian-Yoon Chong, Chay-Hoon Tan, Ee-Heok Kua, Senta Fujii, Kang Sim, Michael K H Yong, Jitendra K Trivedi, Eun-Kee Chung, Pichet Udomratn, Kok-Yoon Chee, Norman Sartorius, Naotaka Shinfuku.   

Abstract

INTRODUCTION: Little is known about the prescription patterns of adjunctive antidepressants in Asian schizophrenia patients. This study aimed to examine trends in the use of antidepressants and their demographic and clinical correlates in the treatment of schizophrenia in Asia between 2001 and 2009.
METHODS: A total of 6,761 hospitalized schizophrenia patients in nine Asian countries and territories were examined: 2,399 in 2001, 2,136 in 2004 and 2,226 in 2009. Patients' socio-demographic and clinical characteristics and prescriptions of psychotropic drugs were recorded using a standardized protocol and data collection procedure.
RESULTS: The proportion of antidepressant prescription was 6.8% in the whole sample; 5.3% in 2001, 6.5% in 2004 and 8.7% in 2009. There were wide inter-country variations at each survey ranging from 0.9% in Hong Kong to 15.3% in Singapore in 2001; from 1.9% in Korea to 15.4% in Singapore in 2004; and from 2.7% in Japan to 22.0% in Singapore in 2009. Multiple logistic regression analysis of the whole sample revealed that patients on antidepressants were younger, more likely to receive benzodiazepines and have significant extrapyramidal side-effects and less likely to have significant positive symptoms. DISCUSSION: Unlike findings in Western countries, adjunctive antidepressant prescription for schizophrenia was not common in Asia. The frequency of antidepressant prescription varied among countries and territories, suggesting that a host of clinical and socio-cultural factors played a role in determining antidepressant use in Asia.
Copyright © 2012 Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  antidepressant; prescription pattern; schizophrenia

Mesh:

Substances:

Year:  2012        PMID: 23857816     DOI: 10.1111/j.1758-5872.2012.00231.x

Source DB:  PubMed          Journal:  Asia Pac Psychiatry        ISSN: 1758-5864            Impact factor:   2.538


  4 in total

1.  Trends in the access to and the use of antipsychotic medications and psychotropic co-treatments in Asian patients with schizophrenia.

Authors:  Y-T Xiang; G S Ungvari; C U Correll; H F K Chiu; N Shinfuku
Journal:  Epidemiol Psychiatr Sci       Date:  2015-08-20       Impact factor: 6.892

2.  Indian Psychiatric Society multicentric study: Prescription patterns of psychotropics in India.

Authors:  Sandeep Grover; Ajit Avasthi; Vishal Sinha; Bhavesh Lakdawala; Manish Bathla; Sujata Sethi; D M Mathur; Puneet Kathuria; Sandip Shah; D Sai Baalasubramanian; Vivek Agarwal; Kamla Deka
Journal:  Indian J Psychiatry       Date:  2014-07       Impact factor: 1.759

Review 3.  Augmentation with antidepressants in schizophrenia treatment: benefit or risk.

Authors:  Ye-Meng Mao; Ming-Dao Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-16       Impact factor: 2.570

4.  Indian psychiatric society multicentric study: Correlates of prescription patterns of psychotropics in India.

Authors:  Sandeep Grover; Ajit Avasthi; Vishal Sinha; Bhavesh Lakdawala; Manish Bathla; Sujata Sethi; D M Mathur; Puneet Kathuria; Sandip Shah; D Sai Baalasubramanian; Vivek Agarwal; Kamla Deka
Journal:  Indian J Psychiatry       Date:  2016 Oct-Dec       Impact factor: 1.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.